000			02119cam a22005414a 4500
001			P 1945
005			20140212102815.0
008			080925s2008 njua b 001 0 eng c
010			_a 2008938265 _z 2008938268
015			_aGBA871787 _2bnb
016	7		_a014627855 _2Uk
016	7		_a101493871 _2DNLM
020			_a1588296466 (hbk. : alk. paper)
020			_a1603270884 (e-ISBN)
020			_a9781588296467 (hbk. : alk. paper)
020			_a9781603270885 (e-ISBN)
035			_a(OCoLC)ocn166358032
040			_aNLM _cNLM _dUKM _dBTCTA _dBAKER _dYDXCP _dBWX _dLTL _dDLC _dIG# _dDLC
042			_apcc
050	0	0	_aRC271.G45 _bG48-2008
060	0	0	_a2009 A-696
060	1	0	_aQV 269 _bG335 2008
082	0	0	_a616.99/4042 _222
245	0	0	_aGenomics and pharmacogenomics in anticancer drug development and clinical response / _cedited by Federico Innocenti.
260			_aTotowa, NJ : _bHumana, _cc2008.
300			_axiv, 377 p. : _bill. ; _c27 cm.
490	1		_aCancer drug discovery and development
504			_aIncludes bibliographical references and index.
505			_aGenomic experimental approaches in oncology -- Pharmacogenomics of toxicity and response of chemotherapy -- Pharmacogenomics in clinical drug development in oncology.
650		0	_aAntineoplastic agents _xDevelopment.
650		0	_aCancer _xGenetic aspects.
650		0	_aCancer _xMolecular aspects.
650		0	_aDrug development.
650		0	_aGenomics.
650		0	_aPharmacogenomics.
650	1	2	_aAntineoplastic Agents.
650	2	2	_aGenomics.
650	2	2	_aNeoplasms _xdrug therapy.
650	2	2	_aNeoplasms _xgenetics.
650	2	2	_aPharmacogenetics _xmethods.
700	1		_aInnocenti, Federico.
830		0	_aCancer drug discovery and development.
906			_a7 _bcbc _cpccadap _d2 _eepcn _f20 _gy-gencatlg
925	0		_aacquire _b2 shelf copies _xpolicy default
942			_cBK
955			_wrd03 2009-07-02
999			_c6953 _d6953